Clinical Trials Directory

Trials / Terminated

TerminatedNCT04452630

Cardiovascular Consequences After COVID-19

The CardioPostCovid Study: Cardiovascular Consequences After COVID-19

Status
Terminated
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus. The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients. This problematic could lead to a second major public health problem linked to Covid-19 and it is therefore crucial to keep monitoring and screening patients at risk. In this context of emerging infectious diseases, of poorly characterized cardiovascular damages during infection and of absence of data on the long-term evolution of the infection, the investigators propose to carry out a prospective and observational cohort study focused on the evaluation and the systematic cardiovascular follow up of patients who survived an episode of Covid-19, regardless of their cardiovascular profiles.

Conditions

Interventions

TypeNameDescription
OTHERInfectious Disease and Cardiology Clinical ConsultationsInfectious Diseases and Cardiology Clinical Consultations at 1 month and 12 months of recovery from an episode of Covid-19

Timeline

Start date
2020-06-23
Primary completion
2023-02-01
Completion
2023-02-01
First posted
2020-06-30
Last updated
2025-11-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04452630. Inclusion in this directory is not an endorsement.

Cardiovascular Consequences After COVID-19 (NCT04452630) · Clinical Trials Directory